Sleep reduces the brain’s predictive ability
03.03.2015 - Communiqué
A study carried out at NeuroSpin (French Atomic Energy Commission [CEA]/Inserm) has shown that even though sounds continue to penetrate the auditory cortex, sleep disrupts the brain’s ability to anticipate them ...
Médecine/sciences (m/s) journal is 30 years old
02.03.2015 - Communiqué
To celebrate the 30 years of the Médecine/sciences journal, a colloquium is organised the thursday 12th March by Inserm at the Pasteur Institute ...
VEGF-C, an indispensable growth factor for producing new neurons
27.02.2015 - Communiqué
Research studies bringing together Inserm, CNRS and Université de Pierre et Marie Curie researchers from the Brain and Spinal Cord Institute in collaboration with a team from the Yale Cardiovascular Research Center, have demonstrated the importance of factor VEGF-C in the activation ...
European Patent Office rankings for 2014: Inserm 6th in France for patent applications, 1st in Europe for patent applications in biomedical research
26.02.2015 - Communiqué
Inserm, with the help of its subsidiary Inserm Transfert, continues to rise in the 2014 rankings of French patent applicants issued by the European Patent Office (EPO) ...
Preliminary results of the JIKI clinical trial to test the efficacy of favipiravir in reducing mortality in individuals infected by Ebola virus in Guinea.
24.02.2015 - Communiqué
Preliminary data from the JIKI clinical trial, which is testing the efficacy of favipiravir in reducing mortality associated with Ebola, provide two important pieces of information: • absence of efficacy in individuals who arrive at treatment centres with a very high level of viral ...
Severe asthma: gallopamil confirmed as a therapeutic approach
18.02.2015 - Communiqué
A team of Inserm researchers from the Cardio-Thoracic Research Centre of Bordeaux has demonstrated the clinical efficacy of gallopamil in 31 patients with severe asthma. ...
Foetal growth restriction (FGR): assessment and impact of screening
16.02.2015 - Communiqué
An observational study carried out in France by Jennifer Zeitlin and her team, on over 14,000 women, shows that only 21% of infants with foetal growth restriction (FGR) had been suspected of having FGR during pregnancy. ...